Filing Details

Accession Number:
0001127602-10-008867
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-16 13:00:00
Reporting Period:
2010-03-15
Filing Date:
2010-03-16
Accepted Time:
2010-03-16 19:05:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882796 Biocryst Pharmaceuticals Inc BCRX Biological Products, (No Disgnostic Substances) (2836) 621413174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1033507 P Zola Horovitz 2190 Parkway Lake Drive
Birmingham AL 35244-
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-15 10,000 $2.60 13,000 No 4 M Direct
Common Stock Disposition 2010-03-15 10,000 $7.22 3,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-03-15 10,000 $0.00 10,000 $2.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-05-14 2013-05-14 No 4 M Direct
Footnotes
  1. Transacted under a 10b5-1 plan that was adopted on 11/24/2009.
  2. The price in column 4 is a weighted average price. The prices actually ranged from $7.11 to $7.35. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.